Toll Free: 1-888-928-9744

VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the VentiRx Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of VentiRx Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of VentiRx Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of VentiRx Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the VentiRx Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

- Evaluate VentiRx Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of VentiRx Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the VentiRx Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of VentiRx Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of VentiRx Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of VentiRx Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
VentiRx Pharmaceuticals, Inc. Snapshot 4
VentiRx Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
VentiRx Pharmaceuticals, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
VentiRx Pharmaceuticals, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
VentiRx Pharmaceuticals, Inc. - Pipeline Products Glance 9
VentiRx Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
VentiRx Pharmaceuticals, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
VentiRx Pharmaceuticals, Inc. - Drug Profiles 13
motolimod 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
VTX-1463 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
VTX-378 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
VTX-294 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
VentiRx Pharmaceuticals, Inc. - Pipeline Analysis 19
VentiRx Pharmaceuticals, Inc. - Pipeline Products by Target 19
VentiRx Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 20
VentiRx Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 21
VentiRx Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 22
VentiRx Pharmaceuticals, Inc. - Recent Pipeline Updates 23
VentiRx Pharmaceuticals, Inc. - Dormant Projects 25
VentiRx Pharmaceuticals, Inc. - Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28
List of Tables
VentiRx Pharmaceuticals, Inc., Key Information 4
VentiRx Pharmaceuticals, Inc., Key Facts 4
VentiRx Pharmaceuticals, Inc. - Pipeline by Indication, 2014 6
VentiRx Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 7
VentiRx Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 8
VentiRx Pharmaceuticals, Inc. - Phase II, 2014 9
VentiRx Pharmaceuticals, Inc. - Phase I, 2014 10
VentiRx Pharmaceuticals, Inc. - Preclinical, 2014 11
VentiRx Pharmaceuticals, Inc. - Discovery, 2014 12
VentiRx Pharmaceuticals, Inc. - Pipeline by Target, 2014 19
VentiRx Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 20
VentiRx Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 21
VentiRx Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 22
VentiRx Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 23
VentiRx Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 25 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify